CRIS Current Research Information System

TRAZZI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.990
EU - Europa 2.550
AS - Asia 2.526
AF - Africa 309
SA - Sud America 113
OC - Oceania 4
Totale 8.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.956
IT - Italia 1.073
SG - Singapore 724
CN - Cina 695
VN - Vietnam 588
GB - Regno Unito 382
DE - Germania 300
HK - Hong Kong 205
SE - Svezia 165
NL - Olanda 142
IN - India 106
IE - Irlanda 99
TG - Togo 90
SC - Seychelles 83
BR - Brasile 82
CI - Costa d'Avorio 76
KR - Corea 76
RU - Federazione Russa 75
FR - Francia 66
BG - Bulgaria 39
JO - Giordania 34
FI - Finlandia 31
ZA - Sudafrica 31
CH - Svizzera 29
ES - Italia 29
JP - Giappone 29
NG - Nigeria 24
CA - Canada 22
ID - Indonesia 22
UA - Ucraina 22
AT - Austria 21
EE - Estonia 21
AR - Argentina 18
BE - Belgio 18
PL - Polonia 11
MX - Messico 9
TR - Turchia 9
BD - Bangladesh 7
HR - Croazia 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
AU - Australia 4
PE - Perù 4
DK - Danimarca 3
GR - Grecia 3
MA - Marocco 3
PK - Pakistan 3
CL - Cile 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
LB - Libano 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GI - Gibilterra 1
HN - Honduras 1
IQ - Iraq 1
IS - Islanda 1
LK - Sri Lanka 1
LV - Lettonia 1
NP - Nepal 1
PT - Portogallo 1
SA - Arabia Saudita 1
SM - San Marino 1
TT - Trinidad e Tobago 1
Totale 8.492
Salva come PNG Salva come JPEG
Città #
Singapore 545
Bologna 408
Ashburn 371
Chandler 337
Fairfield 290
Southend 255
Hong Kong 197
Hefei 175
Houston 146
Ho Chi Minh City 140
Santa Clara 139
Woodbridge 131
Wilmington 129
Dong Ket 128
Seattle 127
Ann Arbor 110
Dublin 98
Hanoi 96
Beijing 95
Lomé 90
Cambridge 87
Dallas 85
Abidjan 76
Seoul 75
Princeton 72
Boardman 67
Turin 56
Bristol 54
Frankfurt am Main 49
Milan 39
Sofia 39
New York 35
Amman 34
Falls Church 34
Los Angeles 34
Redmond 34
Trento 31
Islington 29
Westminster 28
Marano 27
Nanjing 27
Berlin 26
Buffalo 26
Munich 26
Rome 26
Bern 25
Padova 25
Helsinki 24
Tokyo 22
Argelato 21
San Diego 21
Abeokuta 20
Amsterdam 19
Bremen 19
Bengaluru 17
Brussels 17
Redondo Beach 16
Bonn 15
Hebei 15
Jerez De La Frontera 15
Vienna 15
Castel Maggiore 14
Saint Petersburg 14
Bolzano 13
Changsha 13
Jakarta 13
Redwood City 13
Shanghai 12
Tianjin 12
Nanchang 11
Da Nang 10
Des Moines 10
Falkenstein 10
Forlì 10
Guangzhou 10
Rimini 10
Toronto 10
Chicago 9
Florence 9
Biên Hòa 8
Haiphong 8
Jinan 8
London 8
Medford 8
Modena 8
Paris 8
San Francisco 8
Taizhou 8
Warsaw 8
Wuhan 8
Bari 7
Carpi 7
Cesena 7
Dearborn 7
Lanzhou 7
Orem 7
Phủ Lý 7
Pune 7
Quận Một 7
Ravenna 7
Totale 5.790
Salva come PNG Salva come JPEG
Nome #
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 351
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 293
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 289
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder 257
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 247
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 234
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 226
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 226
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 224
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 220
Functional impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are ameliorated by a GABAB receptor antagonist 220
Artificial protein and its applications 208
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 208
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 201
The C-Terminal Domain of CENP-C Displays Multiple and Critical Functions for Mammalian Centromere Formation. 198
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 195
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 195
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 189
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 187
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 186
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 186
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 183
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 180
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 176
Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice 175
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 174
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 172
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 170
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 163
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 163
Functional cooperation between TrkA and p75NTR accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities 161
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 160
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 152
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder 152
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 151
DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions 148
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 145
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 143
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 136
null 130
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 127
CENP-C binds the alpha-satellite DNA in vivo at specific centromere domains 124
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 116
null 101
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder 86
In vivo functional dissection of human inner kinetochore protein CENP-C 80
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 71
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome 49
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease 42
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in Mice 36
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion products 28
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiency 21
Totale 8.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.919
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021496 0 0 0 0 0 73 14 32 58 48 24 247
2021/2022926 62 45 73 70 86 56 42 57 44 78 166 147
2022/20231.420 111 227 74 168 120 122 38 81 228 33 110 108
2023/2024552 27 40 23 55 28 100 71 62 44 23 28 51
2024/20251.653 104 165 141 144 208 93 100 58 80 168 109 283
2025/20262.187 394 626 355 310 477 25 0 0 0 0 0 0
Totale 8.655